期刊
CLINICAL CASE REPORTS
卷 8, 期 12, 页码 3243-3246出版社
WILEY
DOI: 10.1002/ccr3.3325
关键词
atopic dermatitis; dermatology; eczema; JAK inhibitors; tofacitinib
Atopic dermatitis (AD) is a common skin disease, associated with high burden impact in quality of live, in moderate-severe disease severity. Several targeted drugs are under development for AD. Here, we present a patient with refractory disease to systemic traditional immunosuppressive drugs, treated successfully with oral tofacitinib, with complete response.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据